Max-Planck – Focus Symposium – Host-directed therapy : New ways to curing infections

Published on 29/01/2016

November 16th to 17th, 2015

Berlin

The aim of the conference is to bring together pioneers in this emerging research area, discuss their most recent findings and future applications, as well as potential constraints of the approach for medical use. To this end, key scientists in the field as well as experts from the pharmaceutical industries will present their latest results and provide their views on the importance of new treatment strategies. Apart from placing emphasis on science, this conference also aims to raise public awareness, and we have therefore invited representatives from leading press representatives.

Dr. Vincent Lotteau’s talk : “Drug discovery: Lessons from viruses”

http://meeting2015.stiftung-focus-biomed.de

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US